Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients

BMC Psychiatry
Amir GhaderiZatollah Asemi

Abstract

This study determined the effects of a novel combination of vitamin D and probiotic on metabolic and clinical symptoms in chronic schizophrenia. This trial was conducted among 60 patients with chronic schizophrenia to receive either 50,000 IU vitamin D3 every 2 weeks plus 8 × 109 CFU/day probiotic (n = 30) or placebo (n = 30) for 12 weeks. Vitamin D and probiotic co-supplementation was associated with a significant improvement in the general (- 3.1 ± 4.7 vs. + 0.3 ± 3.9, P = 0.004) and total PANSS scores (- 7.4 ± 8.7 vs. -1.9 ± 7.5, P = 0.01). Vitamin D and probiotic co-supplementation also significantly increased total antioxidant capacity (+ 51.1 ± 129.7 vs. -20.7 ± 53.3 mmol/L, P = 0.007), and significantly decreased malondialdehyde (- 0.3 ± 0.9 vs. + 0.2 ± 0.4 μmol/L, P = 0.01) and high sensitivity C-reactive protein levels (- 2.3 ± 3.0 vs. -0.3 ± 0.8 mg/L, P = 0.001) compared with the placebo. Moreover, taking vitamin D plus probiotic significantly reduced fasting plasma glucose (- 7.0 ± 9.9 vs. -0.2 ± 9.9 mg/dL, P = 0.01), insulin concentrations (- 2.7 ± 2.3 vs. + 0.4 ± 2.0 μIU/mL, P < 0.001), homeostasis model of assessment-estimated insulin resistance (- 0.8 ± 0.7 vs. + 0.1 ± 0.7, P < 0.001), triglycerides (- 7.8 ± 25.2...Continue Reading

References

Sep 19, 2000·Medicine and Science in Sports and Exercise·B E AinsworthA S Leon
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zhiping LiAnna Mae Diehl
May 2, 2003·The British Journal of Nutrition·Armin Zittermann
Aug 4, 2004·Archives of Pediatrics & Adolescent Medicine·Andrés MartinDouglas Leslie
Mar 23, 2007·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Joanna Moncrieff
Aug 3, 2010·Antioxidants & Redox Signaling·Kodavali V ChowdariVishwajit L Nimgaonkar
Dec 28, 2010·Clinical Biochemistry·Etiane TatschRafael Noal Moresco
Feb 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Rochellys Diaz HeijtzSven Pettersson
Sep 21, 2011·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Z GuoW Chen
Feb 4, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yong ZhangElena Goleva
Jul 19, 2012·PloS One·Anna-Maija TolppanenDebbie A Lawlor
Jul 25, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Klaus-Peter LeschLise Gutknecht
Jan 15, 2013·Clinical Reviews in Allergy & Immunology·Yoav ArnsonHoward Amital
Jan 23, 2013·Neuropathology and Applied Neurobiology·G C DeLucaG C Ebers
May 21, 2013·Biological Psychiatry·Joshua FlatowBrian J Miller
May 23, 2013·International Clinical Psychopharmacology·Neelam ThakurathiDavid C Henderson
May 30, 2013·Infectious Disorders Drug Targets·Jaana Suvisaari, Outi Mantere
Jun 14, 2013·Biological Psychiatry·Timothy G DinanJohn F Cryan
Feb 22, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rhonda P Patrick, Bruce N Ames
Mar 13, 2014·The Journal of Clinical Endocrinology and Metabolism·E LairdJ J Strain
Jul 23, 2014·The Journal of Clinical Endocrinology and Metabolism·Ghazaleh ValipourAhmad Esmaillzadeh
Jan 15, 2015·The Australian and New Zealand Journal of Psychiatry·Julia J RucklidgeRoger T Mulder
Sep 12, 2015·The Lancet. Psychiatry·Jerome SarrisUNKNOWN International Society for Nutritional Psychiatry Research
Jan 16, 2016·Evidence-based Mental Health·Mathew ChiangXiaoduo Fan

❮ Previous
Next ❯

Citations

Apr 1, 2020·Frontiers in Psychiatry·Tomasz SzeligowskiPhilip W J Burnet
Jul 16, 2020·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Jaqueline S GenerosoTatiana Barichello
Jul 28, 2020·Critical Reviews in Food Science and Nutrition·Valentina StacchiottiFrancesco Galli
Sep 12, 2020·Irish Journal of Psychological Medicine·D Viani-WalshJ Lally
Oct 22, 2020·Brain Sciences·Samskruthi Madireddy, Sahithi Madireddy
Jan 28, 2021·Molecular Psychiatry·Xiaoying CuiDarryl W Eyles
Feb 14, 2021·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Ling ZongXin Wang
Nov 19, 2020·Clinical Nutrition Research·Hee Yun Cha, Soo Jin Yang
Feb 17, 2021·The Cochrane Database of Systematic Reviews·Masuma Pervin MishuNajma Siddiqi
Jun 24, 2021·Behavioral and Brain Functions : BBF·Enrico PatronoAleš Stuchlík
Jul 28, 2020·CNS & Neurological Disorders Drug Targets·Qin HuangJian Xia
Jul 25, 2021·International Journal of Molecular Sciences·Nayla MunawarFadwa Al Mughairbi
Jul 31, 2021·FEMS Microbiology Letters·Gargi Dey, Sohom Mookherjee
Jun 23, 2021·Current Opinion in Psychiatry·Jerzy Samochowiec, Błażej Misiak
Aug 28, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Katarzyna SocałaPiotr Wlaź
Sep 12, 2021·Schizophrenia Research·Jonathan TsiglopoulosBrian O'Donoghue
Feb 2, 2022·Journal of Bone and Mineral Metabolism·Jing ChengBang-Mao Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
MDA

Software Mentioned

Statistical Package for Social Science

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.